The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
New Targeted Therapies and Immunotherapies for Metastatic Non-Small Cell Lung Cancer
Date
March 20, 2021
Learning Objectives
Review the specific appropriate targeted therapy for patients with metastatic non-small cell lung cancer (NSCLC) who have certain actionable oncogenic biomarkers.
Describe the appropriate immunotherapy regimens for patients with metastatic NSCLC who are not eligible for targeted therapies.
Select the optimal treatment for their patients with metastatic NSCLC.
